| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/21/2009 | US7563959 Hybrid maize plant and seed X5P505 |
| 07/21/2009 | US7563953 Soybean cultivar 6836085 |
| 07/21/2009 | US7563949 Comprises nucleotide sequences and vectors coding genes associated with fatty acid biosynthesis for producing seeds with increased oleic acid and decreased linolenic acid; food processing; vegetable oils; desaturases |
| 07/21/2009 | US7563944 Expression cassette for nucleic acids in plant tissue containing starch |
| 07/21/2009 | US7563943 improved oil quantity phenotype or an improved meal quality phenotype due to altered expression of an HIO nucleic acid; introducing into progenitor cells of the plant a plant transformation vector containing a HIO nucleotide sequence that encodes HIO polypeptide; targeting induced local lesions in genome |
| 07/21/2009 | US7563942 Generation of plants with altered oil content |
| 07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
| 07/21/2009 | US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 07/21/2009 | US7563879 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 07/21/2009 | US7563878 Bacterial phytases and method for producing same |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563867 PRO4356 polypeptides |
| 07/21/2009 | US7563863 Plastid transit peptides |
| 07/21/2009 | US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 07/21/2009 | US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 07/21/2009 | US7563777 Method to induce neovascular formation and tissue regeneration |
| 07/21/2009 | US7563776 First sequence of human low affinity nerve growth factor receptor or a polynucleotide coding for it and a second sequence of a mutant hiv nef gene or a polynucleotide coding for it |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563619 low density lipoprotein receptor-related protein 5 (LRP5) is a cell surface marker for somatic mammary stem cells and mammary tumor stem cells; enriching somatic mammary stem cells by contacting with anti(LRP5) antibody; selecting cells that bind to the antibody |
| 07/21/2009 | US7563618 Oligonucleotide conjugates |
| 07/21/2009 | US7563617 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 07/21/2009 | US7563614 Systems and methods for rapidly changing the solution environment around sensors |
| 07/21/2009 | US7563612 Androgen-excess-mediated disease conditions; immunocontraception; polycystic ovarian syndrome, Klinefelter's Syndrome, and prostatic hyperplasia |
| 07/21/2009 | US7563608 Method for manufacturing a sintered compact for use as a cell culture base |
| 07/21/2009 | US7563599 Reshaped human antibody to human medulloblastoma cells |
| 07/21/2009 | US7563596 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes |
| 07/21/2009 | US7563593 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 07/21/2009 | US7563589 Including EED, EZH2 and SUZ12 wherein the reconstituted complex has histone methyltransferase (HMTase) activity for lysine 27 of histone H3 (H3-K27); cancer |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563444 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | US7563438 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 07/21/2009 | US7563278 Drug-eluting intravascular prostheses and methods of use |
| 07/21/2009 | CA2253348C Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 07/21/2009 | CA2104643C Serum free medium |
| 07/17/2009 | WO2008085879A2 Stem cell growth media and methods of making and using same |
| 07/17/2009 | CA2711267A1 Stem cell growth media and methods of making and using same |
| 07/16/2009 | WO2009089493A2 Nitrate amino acid chelates |
| 07/16/2009 | WO2009089476A1 Adult human cardiac-derived progenitor cells |
| 07/16/2009 | WO2009089067A2 Methods and compositions for identifying undifferentiated stem cells and assessing cell health |
| 07/16/2009 | WO2009089035A1 Methods and systems for expanding ac133+ cells and directing differentiation |
| 07/16/2009 | WO2009088837A2 Methods and products to target, capture and characterize stem cells |
| 07/16/2009 | WO2009088405A2 System and method utilizing the expression of tlk1b protein in normal human cells to protect against dna damage |
| 07/16/2009 | WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF |
| 07/16/2009 | WO2009088088A1 Instrument and method for treating minor amount of biological material |
| 07/16/2009 | WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088032A1 Antibody directed against pcrv |
| 07/16/2009 | WO2009088023A1 Culture bag and cell culture method |
| 07/16/2009 | WO2009087929A1 Novel glucose dehydrogenase |
| 07/16/2009 | WO2009087213A1 Osteogenic differentiation of bone marrow stem cells and mesenchymal stem cells using a combination of growth factors |
| 07/16/2009 | WO2009087173A2 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
| 07/16/2009 | WO2009087087A1 Improved culture media additive and process for using it |
| 07/16/2009 | WO2009086596A1 Method of producing a population of cells |
| 07/16/2009 | WO2009043057A3 Cell rolling separation |
| 07/16/2009 | WO2009027654A8 Regionalised endoderm cells and uses thereof |
| 07/16/2009 | WO2009026317A3 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 07/16/2009 | WO2009022158A8 Thermophilic micro-organisms for ethanol production |
| 07/16/2009 | WO2008137280A8 Compositions and methods for altering pancreas or liver function |
| 07/16/2009 | WO2008099185A8 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/16/2009 | WO2008043145A8 Hybridomas producing antibodies against non functional p2x7 receptor |
| 07/16/2009 | WO2008015383A8 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 07/16/2009 | WO2008001045A8 Members of the glycoside hydrolase family 31 family of proteins |
| 07/16/2009 | WO2007110619A8 Beta-galactosidase with transgalactosylating activity |
| 07/16/2009 | WO2003051720A3 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
| 07/16/2009 | WO2003038054A3 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds |
| 07/16/2009 | WO2002083925A3 Papaya ringspot virus genes |
| 07/16/2009 | US20090183285 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183284 Nucleotide seqeunces mediating male fertility and method of using same |
| 07/16/2009 | US20090183283 Rice promoters for regulation of plant expression |
| 07/16/2009 | US20090183282 Insecticidal compounds and methods for selection thereof |
| 07/16/2009 | US20090183280 Transgenic Plants Modified for Reduced Cadmium Transport, Derivative Products, and Related Methods |
| 07/16/2009 | US20090183279 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183278 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183277 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183276 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183275 Nucleotide seqeunces mediating male fertility and method of using same |
| 07/16/2009 | US20090183273 Nucleotide sequences mediating male fertility and method of using same |
| 07/16/2009 | US20090183272 Nucleotide seqeunces mediating male fertility and method of using same |
| 07/16/2009 | US20090183270 Transgenic plants with enhanced agronomic traits |
| 07/16/2009 | US20090183267 Mouse models carrying a knock-out mutation of the qpct-gene |
| 07/16/2009 | US20090182124 Novel transcription factor having zinc finger domains |
| 07/16/2009 | US20090182063 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 07/16/2009 | US20090182057 Deuterated aminoglycidal compounds |
| 07/16/2009 | US20090182044 Nitrate amino acid chelates |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090181990 Stable amorphous form of pemetrexed disodium |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181951 Parp inhibitors |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181891 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/16/2009 | US20090181888 Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient |
| 07/16/2009 | US20090181851 Promoter, Promoter Control Elements, And Combinations, And Uses Thereof |